• de
  • en
deen

International

Berlin Chemie
  • About us
    • BERLIN-CHEMIE
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • About us
    • BERLIN-CHEMIE
      • Manufacturing & Quality assurance
      • Business Development
    • MENARINI Group
    • Our History
    • Our Goal
    • Executive Board
    • Contact
  • Responsibility
    • Code of Conduct
    • Sustainability & social commitment
    • Code of practice for business partners
  • Press
    • News and Press Releases
    • Media library
  • Jobs & Careers
  • Home >>
  • Contact >>
  • Purchasing Terms >>
  • Quality Requirements API / EXC >>
  • Data Protection Information Notice for Healthcare Professionals >>
  • Data Protection Information Notice for Patients >>
  • Privacy >>
  • Disclaimer >>
  • Imprint >>
  • Sitemap >>
  • Change cookie settings »
Press|News and Press Releases|News Detail
  • News and Press Releases
  • Media library

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

11/13/2020
Read more

Menarini Group: committed to fighting today's COVID-19 pandemic with an eye to averting similar health crises in the future

10/27/2020
Read more

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

7/23/2020
Read more

Menarini Group Completes Acquisition of Stemline Therapeutics

6/10/2020
Read more

Menarini invests 150 million euros in a new pharmaceutical plant in Italy

6/6/2020
Read more

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

5/4/2020
Read more

Helsinn Group Grants Exclusive Licensing Rights to BERLIN-CHEMIE for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region

1/27/2020
Read more

MENARINI: Elcin Barker Ergun appointed as Group CEO

9/12/2019
Read more

Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat

12/21/2018
Read more

Art in a click: MENARINI launches “Pills of Art”

10/25/2018
Read more
1234

LAST NEWS

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in

1/30/2023
Read more

Ibuprofen suspension – exemption to safeguard supply of the population

1/2/2023
Read more

Berlin becomes a transfer region for green chemistry

10/6/2022
Read more

BERLIN-CHEMIE celebrates 30 years of affiliation to the MENARINI Group

9/6/2022
Read more

News archive

Archive

  • Expand/Collapse 2023 (2)
    • 2023, January (2)
  • Expand/Collapse 2022 (5)
    • 2022, October (1)
    • 2022, September (1)
    • 2022, July (1)
    • 2022, May (2)
  • Expand/Collapse 2021 (3)
    • 2021, November (1)
    • 2021, October (1)
    • 2021, April (1)
  • Expand/Collapse 2020 (7)
    • 2020, November (1)
    • 2020, October (1)
    • 2020, July (1)
    • 2020, June (2)
    • 2020, May (1)
    • 2020, January (1)
  • Expand/Collapse 2019 (1)
    • 2019, September (1)
  • Expand/Collapse 2018 (5)
    • 2018, December (1)
    • 2018, October (1)
    • 2018, September (1)
    • 2018, March (2)
  • Expand/Collapse 2017 (4)
    • 2017, June (1)
    • 2017, March (2)
    • 2017, January (1)
  • Expand/Collapse 2016 (6)
    • 2016, December (2)
    • 2016, November (1)
    • 2016, October (1)
    • 2016, May (1)
    • 2016, March (1)

 

Responsibility >>

BERLIN-CHEMIE

International >>

SCROLL TO TOP Berlin Chemie
Berlin Chemie
  • Home
  • Contact
  • Privacy
  • Change cookie settings »
  • Purchasing Terms
  • Quality Requirements API / EXC
  • Imprint
  • Fair Play Menarini
  • Data Protection Information Notice for Healthcare Professionals
  • Data Protection Information Notice for Patients
  • Disclaimer
  • Sitemap

CONTACT
BERLIN-CHEMIE AG - Glienicker Weg 125 - 12489 Berlin - Germany
Tel.: +49 30 6707-0
Directons: » Contact us

© 2023 BERLIN-CHEMIE AG